Cyborg jellyfish could help uncover the depths and mysteries of the Pacific Ocean
At first glance, they look like any other moon jellyfish — soft-bodied, translucent and ghostlike, as their bell-shaped bodies pulse gently through the water. But look closer, and you'll spot a tangle of wires, a flash of orange plastic, and a sudden intentional movement.
These are no ordinary jellies. These are cyborgs.
At the Dabiri Lab at Caltech, which focuses on the study of fluid dynamics and bio-inspired engineering, researchers are embedding microelectric controllers into jellyfish, creating 'biohybrid' devices. The plan: Dispatch these remotely controlled jellyfish robots to collect environmental data at a fraction of the cost of conventional underwater robots — and potentially redefine how we monitor the ocean.
'It fills the niche between high-tech underwater robots and just attaching sensors to animals, which you have little control over where they go,' said Noa Yoder, a graduate student in the Dabiri Lab. 'These devices are very low cost and it would be easy to scale them to a whole swarm of jellyfish, which already exist in nature.'
Jellyfish are perfect for the job in other ways: Unlike most marine animals, jellyfish have no central nervous system and no pain receptors, making them ideal candidates for cybernetic augmentation. They also exhibit remarkable regenerative abilities, capable of regrowing lost body parts and reverting to earlier life stages in response to injury or stress — they can heal in as quickly as 24 hours after the removal of a device.
The project began nearly a decade ago with Nicole Xu, a former graduate student in the Dabiri Lab who is now a professor at the University of Colorado Boulder. Her research has demonstrated that electrodes embedded into jellyfish can reliably trigger muscle contractions, setting the stage for field tests and early demonstrations of the device. Later, another Caltech graduate student, Simon Anuszczyk, showed that adding robotic attachments to jellyfish — sometimes even larger than the jellyfish themselves — did not necessarily impair the animals' swimming. And in fact, if designed correctly, the attachments can even improve their speed and mobility.
There have been several iterations of the robotic component, but the general concept of each is the same: a central unit which houses the sensors used to collect information, and two electrodes attached via wires. 'We attach [the device] and send electric signals to electrodes embedded in the jellyfish,' Yoder explained. 'When that signal is sent, the muscle contracts and the jellyfish swims.' By triggering these contractions in a controlled pattern, researchers are able to influence how and when the jellyfish move — allowing them to navigate through the water and collect data in specific locations.
The team hopes this project will make ocean research more accessible — not just for elite institutions with multimillion-dollar submersibles, but for smaller labs and conservation groups as well. Because the devices are relatively low-cost and scalable, they could open the door for more frequent, distributed data collection across the globe.
The latest version of the device includes a microcontroller, which sends the signal to stimulate swimming, along with a pressure sensor, a temperature sensor and an SD card to log data. All of which fits inside a watertight 3D-printed structure about the size of a half dollar. A magnet and external ballast keep it neutrally buoyant, allowing the jellyfish to swim freely, and properly oriented.
One limitation of the latest iteration is that the jellyfish can only be controlled to move up and down, as the device is weighted to maintain a fixed vertical orientation, and the system lacks any mechanism to steer horizontally. One of Yoder's current projects seeks to address this challenge by implementing an internal servo arm, a small motorized lever that shifts the internal weight of the device, enabling directional movement and mid-swim rotations.
But perhaps the biggest limitation is the integrity of the device itself. 'Jellyfish exist in pretty much every ocean already, at every depth, in every environment," said Yoder.
To take full advantage of that natural range, however, the technology needs to catch up. While jellyfish can swim under crushing deep-sea pressures of up to 400 bar — approximately the same as having 15 African elephants sit in the palm of your hand — the 3D-printed structures warp at such depths, which can compromise their performance. So, Yoder is working on a deep-sea version using pressurized glass spheres, the same kind used for deep-sea cabling and robotics.
Other current projects include studying the fluid dynamics of the jellyfish itself. 'Jellyfish are very efficient swimmers,' Yoder said. 'We wanted to see how having these biohybrid attachments affects that.' That could lead to augmentations that make future cyborg jellyfish even more useful for research.
The research team has also begun working with a wider range of jellyfish species, including upside-down Cassiopeia jellies found in the Florida Keys and box jellies native to Kona, Hawaii. The goal is to find native species that can be tapped for regional projects — using local animals minimizes ecological risk.
'This research approaches underwater robotics from a completely different angle,' Yoder said. 'I've always been interested in biomechanics and robotics, and trying to have robots that imitate wildlife. This project just takes it a step further. Why build a robot that can't quite capture the natural mechanisms when you can use the animal itself?'
This story originally appeared in Los Angeles Times.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best low priced pharma stocks to buy now. From June 20 to 23, Wave Life Sciences presented preclinical data for WVE-007, which is its investigational GalNAc-siRNA targeting INHBE mRNA, at the American Diabetes Association's 85th Annual Scientific Sessions in Chicago. The oral presentation was delivered on June 21 and highlighted WVE-007 as a potential novel and distinct obesity treatment designed to induce healthy weight loss by reducing fat while preserving muscle mass. WVE-007 functions by silencing INHBE mRNA, which in turn reduces the production of Activin E protein. Activin E is a lipolysis suppressor that is upregulated in obesity. By inhibiting Activin E, WVE-007 promotes lipolysis, or fat breakdown. A biotechnology laboratory filled with computers and equipment to support research. Human genetics provides strong support for INHBE as a therapeutic target. Individuals with a protective loss-of-function variant in one copy of the INHBE gene exhibit a healthier cardiometabolic profile, which includes less abdominal fat, lower triglycerides, and reduced risk of type 2 diabetes/T2D and cardiovascular disease/CAD. These individuals also show favorable associations with liver traits, such as reductions in cT1 (reflecting liver inflammation and fibrosis) and ALT (reflecting liver damage), without impacting liver fat. Wave Life Sciences Ltd. (NASDAQ:WVE) is a clinical-stage biotechnology company that designs, develops, and commercializes ribonucleic acid/RNA medicines through PRISM, which is a discovery and drug development platform. While we acknowledge the potential of WVE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Health Line
24 minutes ago
- Health Line
What Conditions Can Mimic ALS?
Conditions like myasthenia gravis, multiple sclerosis, and other motor neuron diseases can mimic amyotrophic lateral sclerosis (ALS) due to similar symptoms. Doctors may need several tests to rule out other conditions. ALS is a neurodegenerative disorder characterized by the progressive loss of motor neurons in the brain and spinal cord, leading to muscle weakness and atrophy. However, several diseases mimic ALS due to overlapping symptoms, making an accurate diagnosis challenging. It can take more than a year to arrive at an accurate ALS diagnosis. Read on to learn more about diseases that mimic ALS, including how doctors distinguish between them and ALS. Symptoms of ALS Common ALS symptoms include: muscle weakness muscle atrophy twitching muscle stiffness difficulty swallowing (dysphagia) difficulty speaking (dysarthria) breathing problems fatigue Myasthenia gravis Myasthenia gravis (MG) is a neuromuscular disorder that can mimic ALS due to shared symptoms like muscle weakness. However, there are distinct differences. MG typically features fluctuating muscle weakness that worsens with use, often starting in the eye muscles. Doctors distinguish MG from ALS through specialized tests like repetitive nerve stimulation, which reveals a characteristic decrease in muscle response. Blood tests can also detect acetylcholine receptor or muscle-specific kinase antibodies, indicating MG. Unlike ALS, which is progressively debilitating with no cure, MG has effective treatments like acetylcholinesterase inhibitors or immunosuppressive medications. Multiple sclerosis Multiple sclerosis (MS) is another neurological condition that can sometimes be mistaken for ALS due to overlapping symptoms. It typically presents with episodes of neurological dysfunction that come and go (relapsing-remitting), while ALS involves progressive, steady motor neuron degeneration. Diagnostic tools like MRI can reveal characteristic MS lesions in the central nervous system, helping to distinguish between the two conditions. Cerebrospinal fluid analysis can also help a doctor distinguish MS from ALS. Unlike ALS, MS has disease-modifying therapies to manage symptoms and slow its progression. Other motor neuron disorders Several motor neuron disorders mimic ALS, including: Primary lateral sclerosis (PLS): PLS is a rare motor neuron disorder characterized by progressive weakness, stiffness, and spasticity in the limbs. But unlike ALS, PLS primarily affects your upper motor neurons. Progressive muscular atrophy (PMA): PMA affects your lower motor neurons, resulting in muscle weakness and wasting. This is similar to ALS but without the upper motor neuron involvement often seen in ALS. Hereditary spastic paraplegia (HSP): This group of genetic disorders causes spasticity and weakness, often starting in the lower limbs. While it shares spasticity with ALS, it doesn't involve motor neuron degeneration. Kennedy's disease: This rare genetic disorder primarily affects the bulbar and spinal regions, causing muscle weakness and atrophy. It can resemble ALS but has distinct genetic markers. It's an X-linked condition, meaning it affects mostly males. Key terms Motor neuron degeneration affects how nerves control muscles. Nerve cells stop sending signals from the brain and spinal cord to the muscles, leading to muscle waste. As it progresses, it can affect other body functions, like speaking or swallowing. Spasticity, a symptom of motor neuron disorders, means tightness or stiffness and can cause uncontrollable movements. Upper motor neurons originate in the brain, more specifically in the cerebral cortex, and travel down to the spinal cord. Lower motor neurons begin in the spinal cord and then travel down to the muscles. Infections like Lyme disease and HIV can present symptoms that mimic ALS. Lyme disease can lead to neurological symptoms such as muscle weakness and spasticity. Distinguishing it from ALS involves a detailed medical history and blood tests for Lyme antibodies. HIV-associated neurological complications, including motor dysfunction, can also mimic ALS. Differentiating between the two depends on HIV testing and other HIV-related symptoms. Hyperthyroidism Hyperthyroidism can mimic ALS symptoms due to muscle weakness, tremors, and weight loss. Doctors can use thyroid function tests to reveal elevated thyroid hormone levels to differentiate hyperthyroidism from ALS. Effective treatment for hyperthyroidism, such as antithyroid medications or radioactive iodine, can resolve symptoms. Vitamin B12 deficiency Vitamin B12 deficiency can cause neurological symptoms resembling ALS, including muscle weakness and numbness. Blood tests revealing low B12 levels confirm the deficiency. Vitamin B12 supplementation can reverse these symptoms, distinguishing it from the irreversible progression of ALS. Post-polio syndrome Post-polio syndrome can mimic ALS, leading to muscle weakness and fatigue. A history of prior polio infection and electromyography (EMG) findings help differentiate it from ALS. Unlike ALS, the weakness in post-polio syndrome is generally stable, and management involves rehabilitation strategies to improve function. Nerve damage Spinal cord compression (myelopathy) or a pinched nerve (radiculopathy), particularly in the neck or lower back, can also cause symptoms similar to ALS. They can also present similar findings on certain diagnostic tests, like EMG. In addition to motor symptoms, radiculopathy also causes sensory loss and neuropathic pain. These symptoms are not commonly seen in ALS. Also, in contrast to ALS, myelopathy can cause severe neck pain and loss of control of the anal sphincter. How do doctors either confirm or rule out ALS? Doctors use a combination of clinical evaluations to assess your medical history and symptoms, looking for signs characteristic of ALS. They can also use diagnostic tests to either confirm or rule out ALS, including: EMG and nerve conduction studies: These tests measure electrical activity in muscles and nerves. In ALS, EMG often shows signs of muscle denervation and twitching. MRI and CT scans: Imaging studies can help doctors rule out other diseases that mimic ALS. While they can't confirm ALS, they can indicate muscle atrophy or structural abnormalities. Blood tests: Doctors use blood tests to rule out conditions with similar symptoms, such as thyroid disorders or infections. ALS itself doesn't have specific blood markers.


Bloomberg
44 minutes ago
- Bloomberg
SpaceX Plans Starship Program for In-Orbit Drug Research
By , Edward Ludlow, and Kiel Porter Save SpaceX is working on a program to use its mammoth Starship rocket to develop commercial products in space, potentially opening up a new business line for the world's most valuable private startup, according to people familiar with the matter. Under the plan, internally called Starfall, SpaceX's Starship rocket would bring products like pharmaceutical components to space in small, uncrewed capsules, said one of the people, who spoke on condition of anonymity because the matter is confidential.